20131126

November 2013 P&T Journal Digital Edition




Dear VIJAY PITHADIA:
Your November 2013 digital issue of P&T journal is available.

This issue contains:

Feature articles

  • Overview of Omega-3 Fatty Acids Therapies
    Products containing omega-3 fatty acids, such as krill oil and fish oils, have been effective in lowering triglyceride levels. Although no data have suggested that the low-density lipoprotein-cholesteral (LDL-C) increases associated with some omega-3 fatty acid formulations lead to adverse outcomes, these elevations in LDL-C levels may compromise the achievement of lipid targets. Thus, there is a need for agents that can lower triglyceride levels without increasing LDL-C levels.
     
  • Activated Prothrombin Complex Concentrates For the Reversal of Anticoagulant-Associated Coagulopathy
    Managing hemorrhaging after the use of warfarin and other anticoagulants is challenging. Although an FDA-approved product, FEIBA, has been used as an off-label anticoagulant-reversal agent, the potential risks of thrombosis associated with activated prothrombin complex concentrates must be carefully weighed.
     
  • Qualified Insurance Plans on Health Exchanges May Reduce Drug Availability
    Hospital Pharmacies Could Face New Pressures
    With the Patient Protection and Affordable Care Act going into effect In 2014, hospitals are scrambling to ensure that their formularies meet federal standards.
     
  • MEETING HIGHLIGHTS
    2013 European Cancer Congress
    Therapies for breast cancer, melanoma, lung cancer, and neuroendocrine tumors
     
Plus our regular columns: Medication Errors, Prescription: Washington, New Drugs/Drug News/New Medical Devices, Pharmaceutical Approval Update, and Drug Forecast.
Click here to begin reading the current issue.

Click here to subscribe to P&T journal

Call for Papers
P&T is accepting article submissions from its readers. We welcome a wide variety of manuscripts, including drug class reviews, disease state management reviews, pharmacoeconomic analyses, outcomes research evaluations, DUEs, P&T committee experiences, commentaries, book reviews, and letters to the editor. Please contact Sonja Sherritze, via phone (267-685-2779) or mobile 267-907-5642) or e-mail (ssherritze@medimedia.com) for more information.


We hope you enjoy this issue of P&T. If you have any comments or questions about this digital format, please e-mail us at mail@ptcommunity.com.

Sonja Sherritze
Editor